1 / 4

Psoriatic Arthritis Market

DelveInsightu2019s 'Psoriatic Arthritis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Psoriatic Arthritis therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Psoriatic Arthritis pipeline domain.

Kritika31
Download Presentation

Psoriatic Arthritis Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Psoriatic Arthritis Clinical Trials, Emerging Therapies, Key Companies | A Drug Pipeline Analysis Report 2024 | DelveInsight DelveInsight’s 'Psoriatic Arthritis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Psoriatic Arthritis therapies in various stages pharmaceutical companies are working to advance the pipeline space and future growth potential of the Psoriatic Arthritis pipeline domain. of clinical development, major Key Takeaways from the Psoriatic Arthritis Pipeline Report ● Over 50+ Psoriatic Arthritis pipeline therapies are in various stages of development, and their anticipated acceptance in the Psoriatic Arthritis market would significantly increase market revenue. ● Leading Psoriatic Arthritis companies developing novel drug candidates to improve the Psoriatic Arthritis treatment landscape include AbbVie, and others. ● Promising Psoriatic Arthritis pipeline therapies in various stages of development include ABT-494, Risankizumab, and others. Psoriatic Arthritis Overview Psoriatic Arthritis is a chronic inflammatory disease of the joints that can be associated with the psoriasis. It can affect both peripheral joints and axial skeleton causing pain, stiffness, swelling and joint destruction. This joint pathology develops gradually and cause more nuisance than disabling. Psoriatic arthritis is considered as seronegative spondyloarthropathies. The fact that it is Seronegative is that the blood tests negative for some factors that is present in rheumatoid arthritis. Spondyloarthropathy describes a group of conditions that all share common characteristics. First, there is a presence of arthritis that affects the spine. Second, inflammation occurs in ligaments, tendons and sometimes in other organs such as the eye. Request for a sample report to know more about Psoriatic arthritis treatment algorithm and diagnosis. Psoriatic Arthritis Pipeline Analysis: Drug Profile

  2. Risankizumab: Abbvie Risankizumab is an interleukin-23 (IL-23) inhibitor that selectively blocks IL-23 by binding to its p19 subunit. IL-23, a cytokine involved in inflammatory processes, is thought to be linked to a number of chronic immune-mediated diseases, including psoriasis. Discover more about the emerging Psoriatic Arthritis drugs @ Psoriatic Arthritis Treatment Drugs Psoriatic Arthritis Key Companies ● AbbVie Psoriatic Arthritis Pipeline Therapies ● ABT-494 ● Risankizumab Psoriatic Arthritis Pipeline Therapeutics Assessment ● By development stage ● By product type ● By route of administration ● By molecule type ● By MOA type Scope of the Psoriatic Arthritis Pipeline Report ● Coverage: Global ● Key Psoriatic Arthritis Companies: AbbVie, and others ● Key Psoriatic Arthritis Pipeline Therapies: ABT-494, Risankizumab, and others Find out more about the Psoriatic Arthritis treatment options in development @ Psoriatic Arthritis Clinical Trials Table of Contents 1. Introduction 2. Executive Summary

  3. 3. Overview 4. Pipeline Therapeutics 5. Late-Stage Products (Phase III) 6. Mid-Stage Products (Phase II) 7. Early Stage Products (Phase I/II) 8. Preclinical Stage Products 9. Discovery Stage Products 10. Therapeutic Assessment 11. Inactive Products 12. Collaborations Assessment- Licensing / Partnering / Funding 13. Unmet Needs 14. Market Drivers and Barriers 15. Appendix 16. About DelveInsight Trending Reports by DelveInsight: Adalimumab Biosimilar Market | Arbovirus Infection Market | Artificial Pancreas Device System Market | Dental Equipment Market | Gluten Sensitivity Market | Hypothyroidism Market | Inflammatory Bowel Disease Market | Mayus Kinase Jak Inhibitors Market | Mild Dry Eye Market | Mucopolysaccharidosis Market | Oncolytic Virus Cancer Therapy Market | Pyoderma Gangrenosum Market | Transdermal Drug Delivery Devices Market | Intrathecal Pumps Market | Hedgehog Pathway Inhibitors Market | Yellow Fever Market | Laryngeal Cancer Market | Female Infertility Market | Gender Dysphoria Market | Chronic Brain Damage Market | Spain Healthcare Outlook Market | Malignant Fibrous Histiocytoma Market | Asthma Diagnostic Devices Market | Chronic Obstructive Pulmonary Disease Treatment Devices Market | Airway Management Devices Market | Cough Assist Devices Market | Pulse Oximeters Market | Hemodialysis Catheter Devices Market | Chronic Spontaneous Urticaria Market | Gender Dysphoria Market | Germany Healthcare Outlook | Biopsy Devices Pipeline Insight | Bacterial Conjunctivitis Market | Infliximab Biosimilar Insight | Eosinophilic Asthma Market | Cushing Syndrome Market | Functional Dyspepsia Market | Peripherally Inserted Central Catheters (PICC) Devices Market

  4. About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve. Contact Us Kritika Rehani info@delveinsight.com +91-9650213330

More Related